C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 487/04 (2006.01) A61K 31/4162 (2006.01) A61P 35/00 (2006.01)
Patent
CA 2624519
In its many embodiments, the present invention provides a novel class of pyrazolo[1 ,5-a] pyrimidine compounds as inhibitors of protein and/or checkpoint kinases, methods of preparing such compounds, pharmaceutical compositions including one or more such compounds, methods of preparing pharmaceutical formulations including one or more such compounds, and methods of treatment, prevention, inhibition, or amelioration of one or more diseases associated with the protein or checkpoint kinases using such compounds or pharmaceutical compositions. Formula (I).
Dans ses nombreux modes de réalisation, la présente invention concerne une nouvelle classe de composés pyrazolo[1,5-a]pyrimidines servant d'inhibiteurs de protéines kinases et/ou de kinases "points de contrôle" (checkpoint kinases), des procédés de préparation de tels composés, des compositions pharmaceutiques comprenant un ou plusieurs de ces composés, des procédés de préparation de formulations pharmaceutiques comprenant un ou plusieurs de ces composés et des procédés de traitement, de prévention, d'inhibition ou d'amélioration d'une ou plusieurs maladies associées aux protéines kinases ou aux checkpoint kinases utilisant de tels composés ou de telles compositions pharmaceutiques. Formule (I).
Dwyer Michael P.
Guzi Timothy J.
Paruch Kamil
Shipps Gerald W. Jr.
Norton Rose Or S.e.n.c.r.l. S.r.l./llp
Schering Corporation
LandOfFree
Pyrazolo [1,5-a] pyrimidines as protein kinase inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pyrazolo [1,5-a] pyrimidines as protein kinase inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pyrazolo [1,5-a] pyrimidines as protein kinase inhibitors will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1449386